Skin Cancer: Changing Spots, Evaluation, and UV Protection - Yenra

Describe the change that concerns you

NCI’s skin cancer guide describes changes such as a sore that fails to heal, a shiny or pearly bump, a scar-like area, or a patch that becomes scaly, crusted or bleeds. These findings also have noncancerous causes. Arrange clinical assessment for an unexplained or persistent change rather than trying to identify it from a photograph alone.

Record the location, when you first noticed it, and any change in size, color, texture, bleeding, itching or tenderness. If you already have photographs, bring them with their dates. Taking a picture can help describe change, but should not postpone arranging care.

Melanoma can appear as a changing mole or a new unusual area. NCI’s mole and melanoma guide notes that melanoma also occurs under nails and on palms and soles. People of every skin color can develop skin cancer; include covered and less easily seen areas when explaining your concern. A new or changing nail streak deserves assessment too.

Use ABCDE as a description aid

ABCDE helps organize observations about a pigmented spot. It is a prompt for a professional assessment, with enough flexibility to include small or unusual lesions.

On a small screen, scroll the table sideways. Keyboard users can focus the table region and use the arrow keys.

NCI illustrates the ABCDE features and their limits: melanomas vary, and some show only one or two features. A small diameter or an even color cannot by itself rule out cancer. Bring any spot that is changing or concerning you to a clinician’s attention, even if it fits the list poorly.

Understand the main names

Basal cell carcinoma begins in basal cells of the outer skin layer. Squamous cell carcinoma begins in squamous cells. Melanoma begins in pigment-producing melanocytes. The type affects the likely behavior and the care plan; appearance alone is insufficient to choose a treatment.

The NCI basal-cell and squamous-cell guide and NCI melanoma guide explain these as distinct diagnoses. Many skin cancers can be treated locally, while higher-risk or more extensive disease needs additional assessment. Ask for the exact pathology name and what features make the finding lower or higher risk.

Know what examination and biopsy contribute

At the appointment, explain the change and relevant history: previous skin cancer, immune-suppressing treatment, family history, earlier biopsies and substantial UV exposure. Tell the clinician which area concerns you even if it looks less noticeable that day. Ask whether other areas should be examined.

A biopsy removes some or all of an abnormal area for a pathologist to examine. NCI describes several biopsy techniques; the choice depends on the suspected condition and the site. Ask why the proposed method is suitable, how the area will be numbed, what wound care is needed and when the result will arrive.

• Who will contact me with the result, and whom should I call if it is delayed?
• If cancer is found, what type and other relevant features appear in the report?
• Do the biopsy edges or depth mean another procedure is needed?
• Is further staging or specialist review appropriate?

Use the skin-change appointment notes to bring observations and track the result. Keep the form private and share it with your care team as needed.

Let the diagnosis guide the next step

For basal-cell and squamous-cell cancers, NCI lists surgery and other local treatments, with the choice depending on site, extent and risk. Mohs surgery removes tissue in stages while examining margins. Some situations call for radiation or medicines. Ask how the option balances cancer control, function, appearance and recovery for the affected area.

For melanoma, tumor thickness and other pathology features influence staging and treatment discussions. Surgery is important, and selected situations may involve lymph-node assessment, immunotherapy or targeted treatment. The NCI melanoma treatment guide gives stage-specific context. Request a follow-up plan, including what changes to report and how future skin examinations should be arranged.

Routine screening of people without symptoms is a separate question. The USPSTF’s 2023 statement finds insufficient evidence to recommend for or against clinician visual screening in asymptomatic adolescents and adults within its scope. It excludes people with a personal or family history of skin cancer and does not address assessment of a changing or suspicious lesion.

Make UV protection practical

CDC’s sun-safety guidance recommends protection throughout the year. UV exposure can occur on cloudy or cool days and from reflected sunlight. Use the local UV Index to plan outdoor time, and combine several forms of protection.

• Choose shade and adjust the timing or length of outdoor activities when UV exposure is high.
• Wear clothing that covers the skin, a hat with a brim around the head, and sunglasses that block UVA and UVB.
• Use broad-spectrum sunscreen on exposed skin, applying and reapplying it according to the label. CDC and FDA advise SPF 15 or higher; ask your clinician if your circumstances warrant additional precautions.
• Reapply at least every two hours outdoors and after swimming, sweating or toweling, following the product’s water-resistance directions.
• Avoid indoor tanning. For infants younger than six months, prioritize shade and protective clothing and ask a health professional before using sunscreen.

The FDA sun-safety guide explains that sunscreen works alongside clothing and shade; it does not block all UV. Ask about extra precautions if a medicine increases sun sensitivity or your clinician has identified elevated skin-cancer risk. Protection reduces exposure while observation and follow-up address changes already present.

To place sun protection alongside other risk-reduction priorities, explore the practical cancer-prevention guide.